ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients

Uruga, H; Mino-Kenudson, M

Mino-Kenudson, M (reprint author), Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren 122, Boston, MA 02114 USA.

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2018; 11 (): 147